Refine by
Drug Discovery Program Articles & Analysis
9 news found
“We are excited to expand our common mission and work with the world’s top research hospital and its drug discovery programs.” Under the terms of the collaboration agreement, VeriSIM will leverage its proprietary BIOiSIM™ platform and Translational Index™ approach to reduce the number of outsourced preclinical ...
Sosei Group Corporation (“Sosei Heptares”; TSE: 4565), the international biopharmaceutical company, and New York City-based Kallyope, pioneers in drug discovery involving the gut-brain axis, have entered a strategic research collaboration to identify and validate novel G protein-coupled receptor (GPCR) targets with a goal of creating new ...
New York, United States—April 21, 2022—Total peptide library construction is a powerful technology for new drug research and development at current. As a pioneering peptide company, Creative Peptides developed a total peptide library based on its proprietary peptide design platform, which allows researchers to develop peptide drugs most efficiently. ...
Terray Therapeutics, a biotechnology company propelling drug discovery into the information age, today announced the appointments of Feroze (Fez) Ujjainwalla, PhD, as Head of Business, and Adam D. ...
In addition, the funds will be used to drive forward the company’s drug discovery programs based on the company’s platform in the microbiome gut-brain axis. ...
The use of physiologically relevant in vitro models plays an important role in driving down attrition rates and boosting the efficiency and success of drug discovery programs. It is increasingly clear that standard 2D cell culture fails to accurately reflect the complex interactions that take place in the living body, while animal models are ...
Leveraging its proprietary REVEAL-TxTM disease modeling platform, HemoShear has earned two milestone payments to date in accordance with the Horizon exclusive drug discovery agreement. Each milestone acknowledges the validation of a novel drug target and its advancement to a subsequent stage in Horizon’s early discovery ...
Actym's SAB comprises world-renowned subject matter experts in immuno-oncology, innate immunity, microbiology, novel drug discovery and development. "We are pleased to welcome Drs. Fong and Streuli, two globally recognized experts in immuno-oncology, to Actym's world-class Scientific Advisory Board," said Dr. ...
The award is provided by the Alzheimer's Drug Discovery Foundation (ADDF) Diagnostics Accelerator, a fund set up in collaboration with Bill Gates and other philanthropic partners. ...
ByDiamiR